Similar articles

• Is it time to use observational data to estimate treatment effectiveness in multiple sclerosis?

  Trojano M. Trojano M. Neurology. 2007 Oct 9;69(15):1478-9. doi: 10.1212/01.wnl.0000275545.08382.82. Neurology. 2007. PMID: 17923610 No abstract available.
• More good intentions.

  Anick D. Anick D. Altern Ther Health Med. 2000 May;6(3):23, 119. Altern Ther Health Med. 2000. PMID: 10802904 No abstract available.
• Improving the quality of reports of randomised controlled trials: the CONSORT statement.

  Otwombe KN, Ogutu B. Otwombe KN, et al. East Afr Med J. 2002 Jul;79(7):394-6. East Afr Med J. 2002. PMID: 12638837 No abstract available.
• Fables or foibles: inherent problems with RCTs.

  Rosner A. Rosner A. J Manipulative Physiol Ther. 2003 Sep;26(7):460-7. doi: 10.1016/S0161-4754(03)00094-0. J Manipulative Physiol Ther. 2003. PMID: 12975633 Review. No abstract available.
• Assessment of risk of bias in randomized clinical trials in surgery.

  Gurusamy KS, Gluud C, Nikolova D, Davidson BR. Gurusamy KS, et al. Br J Surg. 2009 Apr;96(4):342-9. doi: 10.1002/bjs.6558. Br J Surg. 2009. PMID: 19283747 Review.